We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Panel Gives Nods for Eight New Drugs, Including Gene Therapy
EMA Panel Gives Nods for Eight New Drugs, Including Gene Therapy
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended eight new drugs for approval during its monthly meeting, including Bluebird Bio’s gene therapy for treating early cerebral adrenoleukodystrophy (CALD), a first for the treatment.